ADC Therapeutics Ownership | Who Owns ADC Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

ADC Therapeutics Ownership Summary

ADC Therapeutics is owned by 63.72% institutional investors, 19.03% insiders, and 17.25% retail investors. Redmile group is the largest institutional shareholder, holding 14.61% of ADCT shares. Biotech Growth Ord is the top mutual fund, with 1.89% of its assets in ADC Therapeutics shares.

ADCT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	ADC Therapeutics	63.72%	19.03%	17.25%
Sector	Healthcare Stocks	487.91%	11.08%	-398.99%
Industry	Biotech Stocks	307.10%	11.11%	-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Redmile group	15.67M	14.61%	$41.99M
Prosight management, lp	10.47M	9.76%	$28.05M
Point72 asset management	7.76M	7.24%	$20.81M
Orbimed advisors	5.91M	5.51%	$15.83M
Blackrock	3.55M	4.31%	$11.23M
Blackrock funding, inc. /de	4.52M	4.22%	$12.12M
Morgan stanley	2.97M	3.59%	$9.37M
Heights capital management	2.83M	2.64%	$7.59M
Nantahala capital management	2.27M	2.11%	$6.07M
Woodline partners lp	1.93M	1.84%	$3.85M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Vantage consulting group	683.00K	31.92%	$1.83M
Prosight management, lp	10.47M	6.84%	$28.05M
Redmile group	15.67M	4.47%	$41.99M
Heights capital management	2.83M	2.03%	$7.59M
Blue owl capital lp	733.57K	0.63%	$1.97M
Orbimed advisors	5.91M	0.40%	$15.83M
Platinum investment management	1.39M	0.25%	$3.72M
Stempoint capital lp	283.29K	0.24%	$759.21K
Nantahala capital management	2.27M	0.24%	$6.07M
Dafna capital management	122.08K	0.09%	$327.18K

Top Buyers

Holder	Shares	% Assets	Change
Point72 asset management	7.76M	0.04%	7.76M
Blackrock	3.55M	0.00%	3.55M
Heights capital management	2.83M	2.03%	2.83M
Nantahala capital management	2.27M	0.24%	2.27M
Woodline partners lp	1.93M	0.03%	1.93M

Top Sellers

Holder	Shares	% Assets	Change
Silverarc capital management	-	-	-1.80M
Siren	-	-	-1.16M
Adage capital partners gp	-	-	-1.00M
Platinum investment management	1.39M	0.25%	-650.82K
Monashee investment management	-	-	-500.00K

New Positions

Holder	Shares	% Assets	Change	Value
Point72 asset management	7.76M	0.04%	7.76M	$20.81M
Blackrock	3.55M	0.00%	3.55M	$11.23M
Heights capital management	2.83M	2.03%	2.83M	$7.59M
Nantahala capital management	2.27M	0.24%	2.27M	$6.07M
Woodline partners lp	1.93M	0.03%	1.93M	$3.85M

Sold Out

Holder	Change
Gradient investments	-11.00
Federation des caisses desjardins du quebec	-20.00
Northwestern mutual wealth management	-36.00
Southstate	-46.00
Goalvest advisory	-50.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	90	8.43%	68,312,257	26.51%	63	2.51%	31	-20.51%	40	81.82%
Mar 31, 2025	84	-2.33%	54,846,273	-2.92%	51	1.76%	39	-20.41%	22	37.50%
Dec 31, 2024	86	8.86%	56,494,277	2.93%	53	1.97%	49	-5.77%	16	45.45%
Sep 30, 2024	78	-	54,783,537	5.76%	52	1.33%	51	-10.53%	11	83.33%
Jun 30, 2024	78	95.00%	51,801,951	49.36%	62	3.48%	57	185.00%	6	-25.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Biotech Growth Ord	2.13M	1.89%	-
iShares Russell 2000 ETF	1.81M	1.61%	-
Fidelity Small Cap Index	726.86K	0.65%	-94.23K
iShares Russell 2000 Growth ETF	628.23K	0.56%	-
iShares Biotechnology ETF	460.15K	0.41%	-
State St Russell Sm/Mid Cp® Indx NL Cl C	401.24K	0.40%	-
State St Russell Sm/Mid Cp® Indx SL Cl I	401.24K	0.36%	-
Vanguard Russell 2000 ETF	344.65K	0.31%	-24.16K
iShares Russell 2000 Value ETF	286.42K	0.29%	-
State St Russell Sm Cap® Indx SL Cl I	305.70K	0.27%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 27, 2025	Redmile Group, LLC	-	Buy	-
Jun 11, 2025	Redmile Group, LLC	-	Buy	-
Jun 11, 2025	Redmile Group, LLC	-	Buy	-
Dec 11, 2024	Redmile Group, LLC	-	Buy	$190.50K
Dec 11, 2024	Redmile Group, LLC	-	Buy	$114.00K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	1	-
2025 Q2	2	-
2025 Q1	-	-
2024 Q4	4	1
2024 Q3	2	-

ADCT Ownership FAQ

Who Owns ADC Therapeutics?

ADC Therapeutics shareholders are primarily institutional investors at 63.72%, followed by 19.03% insiders and 17.25% retail investors. The average institutional ownership in ADC Therapeutics's industry, Biotech Stocks , is 307.10%, which ADC Therapeutics falls below.

Who owns the most shares of ADC Therapeutics?

ADC Therapeutics’s largest shareholders are Redmile group (15.67M shares, 14.61%), Prosight management, lp (10.47M shares, 9.76%), and Point72 asset management (7.76M shares, 7.24%). Together, they hold 31.62% of ADC Therapeutics’s total shares outstanding.

Does Blackrock own ADC Therapeutics?

Yes, BlackRock owns 4.31% of ADC Therapeutics, totaling 3.55M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 11.23M$. In the last quarter, BlackRock increased its holdings by 3.55M shares, a 100.00% change.

Who is ADC Therapeutics’s biggest shareholder by percentage of total assets invested?

Vantage consulting group is ADC Therapeutics’s biggest shareholder by percentage of total assets invested, with 31.92% of its assets in 683K ADC Therapeutics shares, valued at 1.83M$.

Who is the top mutual fund holder of ADC Therapeutics shares?

Biotech Growth Ord is the top mutual fund holder of ADC Therapeutics shares, with 1.89% of its total shares outstanding invested in 2.13M ADC Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools